Regen Nutripharm Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 9.57%
- Profit Growth 7.74%
- Ebitda 84.67%
- Net Worth 13.88%
- Total Assets 42.87%
About Regen Nutripharm
Regen Nutripharm Private Limited (RNPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 March 2016 (Eight years and 11 months 0 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shephali Mudgil and Pawan Mudgil serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900GJ2016PTC086399
-
Company No.
086399
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Mar 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Regen Nutripharm Private Limited offer?
Regen Nutripharm Private Limited offers a wide range of products and services, including Veterinary Medicines, Poultry Medicines, Chemical Reagents & Catalysts, Ammonium Compound, Animal Nutraceuticals, Veterinary Liver Tonic, Fertilizer, Plant Growth Promoters.
Who are the key members and board of directors at Regen Nutripharm?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Mudgil
|
Director | 10-Mar-2016 | Current |
|
Shephali Mudgil
|
Director | 10-Mar-2016 | Current |
Financial Performance of Regen Nutripharm.
Regen Nutripharm Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.57% increase. The company also saw a slight improvement in profitability, with a 7.74% increase in profit. The company's net worth Soared by an impressive increase of 13.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regen Nutripharm?
Unlock access to Regen Nutripharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Regen Phytozenika Private LimitedShephali Mudgil and Pawan Mudgil are mutual person
-
Regen Biocorps Ahi Private Limited
Shephali Mudgil and Pawan Mudgil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regen Nutripharm?
Unlock and access historical data on people associated with Regen Nutripharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regen Nutripharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regen Nutripharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.